Business Practice

Environmental, social, and governance (ESG) plans should be an integral part of any company that aims to thrive in today’s society.

Meet Ori Biotech’s Jason Foster. How did he transition to advanced therapy, and why did he end up in the UK?

Four courageous marketer-knights weigh in on what it takes to tilt against the social media windmills of pharma’s digital content kingdom.

Charlie Badham of 4D Pharma tells us his approach to social media in an age of outrage and tonal mixups.

Mike Rea of IDEA Pharma speaks frankly on the mud fights, echo chambers, and risks at play in the virtual forums of social media in 2021.

When it comes to delivering medicines to patients in need, choosing the right packaging partner can make all the difference.

After a madcap back and forth between leading and dissenting Democrats, Biden’s drug pricing reform plans have reached a compromised final form.

The FDA has approved just three biosimilars in 2021 – but the approvals could shake up the field as discussions around interchangeability intensify.

Biotech companies need good patient samples, but hospitals are not always obliging...

Sai Rangarao has worked for some of the biggest names in pharma. Here’s his advice to digital marketers in the field.